Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial

被引:0
|
作者
Naoto Katakami
Tomoya Mita
Hidenori Yoshii
Toshihiko Shiraiwa
Tetsuyuki Yasuda
Yosuke Okada
Keiichi Torimoto
Yutaka Umayahara
Hideaki Kaneto
Takeshi Osonoi
Tsunehiko Yamamoto
Nobuichi Kuribayashi
Kazuhisa Maeda
Hiroki Yokoyama
Keisuke Kosugi
Kentaro Ohtoshi
Isao Hayashi
Satoru Sumitani
Mamiko Tsugawa
Kayoko Ryomoto
Hideki Taki
Tadashi Nakamura
Satoshi Kawashima
Yasunori Sato
Hirotaka Watada
Iichiro Shimomura
机构
[1] Osaka University Graduate School of Medicine,Department of Metabolic Medicine
[2] Osaka University Graduate School of Medicine,Department of Metabolism and Atherosclerosis
[3] Juntendo University Graduate School of Medicine,Department of Metabolism & Endocrinology
[4] Juntendo Tokyo Koto Geriatric Medical Center,Department of Medicine, Diabetology & Endocrinology
[5] Shiraiwa Medical Clinic,Department of Diabetes and Endocrinology
[6] Osaka Police Hospital,First Department of Internal Medicine, School of Medicine
[7] University of Occupational and Environmental Health,Department of Diabetes and Endocrinology
[8] Japan,Diabetes and Endocrinology
[9] Osaka General Medical Center,Center for Diabetes and Endocrinology
[10] Department of Diabetes,Department of Endocrinology and Metabolism
[11] Endocrinology and Metabolism,Center for Diabetes Mellitus
[12] Kawasaki Medical School,Diabetes Center
[13] Nakakinen Clinic,Department of Internal Medicine
[14] Kansai Rosai Hospital,Department of Preventive Medicine and Public Health
[15] Misaki Naika Clinic,undefined
[16] Kitasenri Maeda Clinic,undefined
[17] Jiyugaoka Medical Clinic,undefined
[18] Kosugi Medical Clinic,undefined
[19] Otoshi Medical Clinic,undefined
[20] Hayashi Clinic,undefined
[21] Nippon Life Hospital,undefined
[22] Ikeda Municipal Hospital,undefined
[23] Osaka Rosai Hospital,undefined
[24] National Hospital Organization Osaka National Hospital,undefined
[25] Kawasaki Hospital,undefined
[26] Kanda Naika Clinic,undefined
[27] Keio University School of Medicine,undefined
来源
关键词
Arterial stiffness; Pulse wave velocity; Arteriosclerosis; Diabetes; SGLT2 inhibitor; Tofogliflozin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
下载
收藏
相关论文
共 50 条
  • [41] Lowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: A multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study)
    Hashimoto-Kameda, Reina
    Cho, Kyu Yong
    Nomoto, Hiroshi
    Nakamura, Akinobu
    Omori, Kazuno
    Nagai, So
    Edagawa, Sachiko
    Kawata, Shinichiro
    Takeuchi, Jun
    Kameda, Hiraku
    Kurihara, Yoshio
    Aoki, Shin
    Atsumi, Tatsuya
    Miyoshi, Hideaki
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 180
  • [42] DAPagliflozin for the attenuation of albuminuria in Patients with hEaRt failure and type 2 diabetes (DAPPER study): a multicentre, randomised, open-label, parallel-group, standard treatment-controlled trial
    Yoshihara, Fumiki
    Imazu, Miki
    Sakuma, Ichiro
    Hiroi, Yukio
    Hara, Hisao
    Okazaki, Osamu
    Ishiguro, Chizuru
    Izumi, Chisato
    Noguchi, Teruo
    Shiraiwa, Toshihiko
    Nishioka, Norio
    Fujii, Kenshi
    Iwakura, Katsuomi
    Tomonaga, Osamu
    Kobayashi, Koichi
    Himi, Toshiharu
    Takihata, Masahiro
    Yumoto, Kazuhiko
    Takase, Hiroyuki
    Shimizu, Ikki
    Murakami, Tsutomu
    Wagatsuma, Kenji
    Sato, Katsuhiko
    Hiramatsu, Takeyuki
    Akabame, Satoshi
    Hata, Shiro
    Asakura, Masanori
    Kawabata, Takanori
    Omae, Katsuhiro
    Ito, Shin
    Kitakaze, Masafumi
    ECLINICALMEDICINE, 2023, 66
  • [43] Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
    Qin, Shukui
    Ren, Zhenggang
    Meng, Zhiqiang
    Chen, Zhendong
    Chai, Xiaoli
    Xiong, Jianping
    Bai, Yuxian
    Yang, Lin
    Zhu, Hong
    Fang, Weijia
    Lin, Xiaoyan
    Chen, Xiaoming
    Li, Enxiao
    Wang, Linna
    Chen, Chunxia
    Zou, Jianjun
    LANCET ONCOLOGY, 2020, 21 (04): : 571 - 580
  • [44] Multifactorial Intervention on Type 2 Diabetes (MIDiab) Study: A multicenter,open-label, randomized, parallel controlled, community trial
    Wang, Yupeng
    Guan, Qingbo
    Hou, Xu
    Zhang, Xu
    Zhang, Haiqing
    Xu, Chao
    Jing, Fei
    Ma, Shizhan
    Shao, Shanshan
    Zhao, Meng
    Guo, Qingling
    Zhong, Fang
    Gao, Ling
    Zhao, Jiajun
    JOURNAL OF DIABETES, 2020, 12 (11) : 862 - 864
  • [45] The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer
    Klotz, Laurence
    Boccon-Gibod, Laurent
    Shore, Neal D.
    Andreou, Cal
    Persson, Bo-Eric
    Cantor, Per
    Jensen, Jens-Kristian
    Olesen, Tine Kold
    Schroeder, Fritz H.
    BJU INTERNATIONAL, 2008, 102 (11) : 1531 - 1538
  • [46] The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer
    Sommerauer, M.
    Doehn, C.
    ONKOLOGE, 2009, 15 (08): : 799 - 801
  • [47] A 12-week, randomized, open-label, parallel-group trial of topiramate in limiting weight gain during olanzapine treatment in patients with schizophrenia
    Kim, J
    Yim, S
    Nam, J
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 86 - 86
  • [48] A 12-week, randomized, open-label, parallel-group trial of topiramate in limiting weight gain during olanzapine treatment in patients with schizophrenia
    Kim, JH
    Yim, SJ
    Nam, JH
    SCHIZOPHRENIA RESEARCH, 2006, 82 (01) : 115 - 117
  • [49] A Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing Patient Satisfaction and Compliance with a Needle-Free Insulin Injector vs. Conventional Insulin Pen Injections in Chinese Patients with Type 2 Diabetes Mellitus
    Wang, Yangang
    Ji, Linong
    Guo, Lixin
    Ran, Xingwu
    Chen, Liming
    Ma, Zhongshu
    Sun, Zilin
    Shan, Zhongyan
    Xu, Xiangjin
    Wang, Guixia
    DIABETES, 2019, 68
  • [50] Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
    Pratley, Richard E.
    Nauck, Michael
    Bailey, Timothy
    Montanya, Eduard
    Cuddihy, Robert
    Filetti, Sebastiano
    Thomsen, Anne Bloch
    Sondergaard, Rie Elvang
    Davies, Melanie
    LANCET, 2010, 375 (9724): : 1447 - 1456